Survivin-targeting miR-542-3p overcomes erbB3 signaling-mediated chemoresistance and enhances the antitumor activity of paclitaxel against erbB2-positive breast cancer
Survivin-targeting miR-542-3p overcomes erbB3 signaling-mediated chemoresistance and enhances the antitumor activity of paclitaxel against erbB2-positive breast cancer
复制标题
靶向生存素的 miR-542-3p 克服了 erbB3 信号传导介导的化疗耐药性，并增强了紫杉醇对 erbB2 阳性乳腺癌的抗肿瘤活性
作者：
Lyu H;Wang SL;Huang JC;Wang BL;He ZM;Liu BL
